Stephen Toovey
Directeur/Bestuurslid bij 60 DEGREES PHARMACEUTICALS, INC.
Vermogen: 3 542 $ op 30-06-2024
Actieve functies van Stephen Toovey
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 12-07-2023 | - |
| Independent Dir/Board Member | 12-07-2023 | - |
Loopbaan van Stephen Toovey
Eerdere bekende functies van Stephen Toovey
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Oprichter | 01-01-2014 | 01-01-2020 |
Opleiding van Stephen Toovey
| Ghent University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| België | 2 |
| China | 2 |
Operationeel
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
- Beurs
- Insiders
- Stephen Toovey
- Ervaring
